Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Zollinger-Ellison Syndrome × Lansoprazole × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Endocrine 1

Conditions

Zollinger-Ellison Syndrome 1 Multiple Endocrine Neoplasia 1 Carcinoma, Neuroendocrine 1 Carcinoid Tumor 1

Interventions

Temozolomide 2 Capecitabine 2 veliparib 1 pazopanib 1 cixutumumab 1 Salts 1 Octreotide 1 Lansoprazole 1 Everolimus 1 Acetates 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00204373 2012-10-30

Treatment of Zollinger-Ellison Syndrome With Prevacid

University of Alabama at Birmingham

Phase 4 Completed

72 enrolled 8 charts

Multiple Endocrine Neoplasia, Zollinger-Ellison Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡